Key result
The relative bioavailability of quinidine oral solution under fed versus non-fed conditions was 75.0% for the loading dose, while the paste formulation showed highly variable bioavailability.
Fasted dosing may improve quinidine solution exposure; leaves open reliable paste formulation selection in veterinary practice.
Quinidine is the drug of choice for the treatment of cardiac arrhythmias in horses. The plasma concentrations vs. time profiles following oral administration of two formulations of quinidine sulphate, an oral solution and an oral suspension paste, were evaluated in nine horses. They received multiple administrations of the oral solution under fed and non-fed conditions and of the paste under non-fed conditions. A loading dose of 20 mg.kg-1 and a maintenance dose of 10 mg.kg-1 quinidine with dosing interval of 6 h were used. The relative bioavailability of the oral solution under fed conditions in comparison to the solution under non-fed conditions was 75.0 +/- 10.2% for the loading dose and 97.18 +/- 31.66% after the fourth dose. For the paste formulation the relative bioavailability values are not reported, as steady-state levels were not reached. There was a large variation in plasma quinidine levels when the paste formulation was administered. Feeding conditions had a significant influence on the Cmax values after administration of the loading dose. The Tmax values were not affected by food intake. It was concluded that an oral solution has to be preferred because of the variable drug bioavailability from the paste formulation and the poor acceptability of the paste by the horse.
No takes yet. Share an insight, caveat, or question.
Bouckaert et al. (1994) studied cardiac arrhythmias (n=9). Quinidine sulphate (oral solution and oral suspension paste) vs. Fed vs non-fed conditions was evaluated on Relative bioavailability of oral solution (fed vs non-fed). The relative bioavailability of quinidine oral solution under fed versus non-fed conditions was 75.0% for the loading dose, while the paste formulation showed highly variable bioavailability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: